首页> 外国专利> N- (hetero) aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo 2,3-d pyrimidines and pyrrol-3-yl-pyrrolo 2,3-d pyrimidines as Janus kinase inhibitors

N- (hetero) aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo 2,3-d pyrimidines and pyrrol-3-yl-pyrrolo 2,3-d pyrimidines as Janus kinase inhibitors

机译:吡唑-4-基-吡咯并[2,3-d]嘧啶和吡咯-3-基-吡咯并[2,3-d]嘧啶的N-(杂)芳基-吡咯烷衍生物作为Janus激酶抑制剂

摘要

A compound of formula I: or a pharmaceutically acceptable salt or N-oxide thereof; in which: X is cyano or halogen; Y is CH or N; Z is hydrogen, C1-4 alkyl, fluorinated C1-4 alkyl or fluorine; Ar is C6-14 aryl, C1-14 heteroaryl, C7-14 cycloalkyl-fused aryl, heterocycloalkyl C6-14-aryl condensed, cycloalkyl C2-14-heteroaryl fused or heterocycloalkyl C2-14-fused heteroaryl, each of which is optionally substituted with 1, 2, 3, 4, 5 or 6 independently selected R1 groups; each R1 is independently selected from halogen, cyano, nitro, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-14 cycloalkyl, C3-14 cycloalkyl-C1-4 alkyl, C2- heterocycloalkyl 14, C2-14 heterocycloalkyl-C1-4 alkyl, C6-14 aryl, C6-14 aryl-C1-4 alkyl, C1-13 heteroaryl, C1-13 heteroaryl-C1-4 alkyl, -ORa, -SR3, -S ( = O) Rb, -S ( = O) 2Rb, -S ( = O) NReRf, -C ( = O) Rb, -C ( = O) ORb, -C ( = O) NReRf, -OC ( = O) Rb, - OC ( = O) NReRf, -NReRf, -NRcC ( = O) Rd, -NRcC ( = O) ORd, -NRcS ( = O) 2Rd and -NRbS ( = O) 2NReRf; wherein said C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl and C2-6 alkynyl are each optionally substituted with independently selected 1, 2, 3 or 4 R1 to 30 groups; and wherein said C3-14 cycloalkyl, C3-14 cycloalkyl-C1-4 alkyl, C2-14 heterocycloalkyl, C2-14 heterocycloalkyl-C1-4 alkyl, C6-14 aryl, C6-14 aryl-C1-4 alkyl, C1-13 heteroaryl and C1-13 heteroaryl-C1-4 alkyl are each optionally substituted with 1, 2, 3 or 4 independently selected R2a groups; Each R1a is independently selected from halogen, cyano, nitro, hydroxyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkylthio, C1-4 alkyl sulfinyl, C1-4 alkyl sulfonyl, amino, C1- alkyl 4-amino, di-C 1-4 alkyl-amino, C 1-4 alkylcarbonyl, carboxy, C 1-4 alkoxycarbonyl, C 1-4 alkylcarbonylamino, C 1-4 alkylcarbonylamino, C 1-4 alkoxy carbonylamino, C 1-4 alkoxycarbonyl- (C 1-4 alkyl) amino, carbamyl, C 1-4 alkylcarbamyl and diC 1-4 alkylcarbamyl; each R2a is independently selected from halogen, cyano, nitro, hydroxy, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 alkoxy, C1-4 haloalkoxy, C1-4 alkyl , C 1-4 alkyl sulfinyl, C 1-4 alkyl sulfonyl, amino, C 1-4 alkyl, di C 1-4 alkyl, C 1-4 alkylcarbonyl, carboxy, C 1-4 alkoxycarbonyl, alkyl C1-4- carbonylamino, di-C1-4 alkylcarbonylamino, C1-4 alkoxycarbonylamino, C1-4 alkoxycarbonyl- (C1-4 alkyl) amino, carbamyl, C1-4 alkylcarbamyl and di-C1 alkyl -4-carbamyl; Each Ra, Rb, Rc, Rd, Re and Rf are independently selected from H, C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl, C2-6 alkynyl, C3-7 cycloalkyl, C3-7 cycloalkyl -4, C2-7 heterocycloalkyl, C2-7 heterocycloalkyl-C1-4 alkyl, phenyl, phenyl-C1-4 alkyl, heteroaryl C1-7 and heteroaryl C1-7-alkyl C1-4 alkyl; wherein said C1-6 alkyl, C1-6 haloalkyl, C2-6 alkenyl and C2-6 alkynyl are each optionally substituted with 1, 2, 3 or 4 independently selected Rx groups; and wherein said C 3-7 cycloalkyl, C 3-7 cycloalkyl-C 1-4 alkyl, C 2-7 heterocycloalkyl, C 2-7 heterocycloalkyl-C 1-4 alkyl, phenyl, phenyl-C 1-4 alkyl, C 1-7 heteroaryl and heteroaryl C1-7-C1-4 alkyl are each optionally substituted with 1, 2, 3 or 4 independently selected Ry groups; or any Rc and Rd, together with the rest to which they are attached, can form a 3, 4, 5, 6 or 7-membered heterocycloalkyl ring, wherein said heterocycloalkyl ring is optionally substituted with 1, 2, 3 or 4 independently selected groups of hydroxyl, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, C 1-4 haloalkoxy, amino, C 1-4 alkyl and di C 1-4 alkyl; or any Re and Rf, together with the nitrogen atom to which they are attached, can form a 3, 4, 5, 6 or 7-membered heterocycloalkyl ring or heteroaryl ring, wherein said heterocycloalkyl or heteroaryl ring is optionally substituted with 1, 2, 3 or 4 groups independently selected from hydroxyl, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, C 1-4 haloalkoxy, amino, C 1-4 alkyl and di C 1-4 alkyl -Not me; each Rx is independently selected from hydroxyl, C 1-4 alkoxy, C 1-4 haloalkoxy, amino, C 1-4 alkyl and di C 1-4 alkyl; and each Ry is independently selected from hydroxyl, halogen, cyano, nitro, C 1-4 alkyl, C 1-4 haloalkyl, C 1-4 alkoxy, C 1-4 haloalkoxy, amino, C 1-4 alkyl and di C 1-4 alkyl -Not me; provided that the valence of each atom in the optionally substituted residues is not exceeded.
机译:式I化合物:或其药学上可接受的盐或N-氧化物;其中:X为氰基或卤素; Y是CH或N; Z为氢,C 1-4烷基,氟化的C 1-4烷基或氟; Ar为C 6-14芳基,C 1-14杂芳基,C 7-14环烷基稠合的芳基,稠合的杂环烷基C 6-1 4芳基,稠合的环烷基C 2-1 4杂芳基或杂环烷基的C 2-1 4稠合的杂芳基,它们各自任选地被取代具有1、2、3、4、5或6个独立选择的R1基团;每个R 1独立地选自卤素,氰基,硝基,C 1-6烷基,C 1-6卤代烷基,C 2-6烯基,C 2-6炔基,C 3-14环烷基,C 3-14环烷基-C 1-4烷基,C 2-杂环烷基14,C2-14杂环烷基-C1-4烷基,C6-14芳基,C6-14芳基-C1-4烷基,C1-13杂芳基,C1-13杂芳基-C1-4烷基,-ORa,-SR3,-S (> = O)Rb,-S(> = O)2Rb,-S(> = O)NReRf,-C(> = O)Rb,-C(> = O)ORb,-C(> = O) NReRf,-OC(> = O)Rb,-OC(> = O)NReRf,-NReRf,-NRcC(> = O)Rd,-NRcC(> = O)ORd,-NRcS(> = O)2Rd和-NRbS(> = O)2NReRf;其中所述的C 1-6烷基,C 1-6卤代烷基,C 2-6烯基和C 2-6炔基各自任选地被独立选择的1、2、3或4个R 1至30个基团取代;并且其中所述C3-14环烷基,C3-14环烷基-C1-4烷基,C2-14杂环烷基,C2-14杂环烷基-C1-4烷基,C6-14芳基,C6-14芳基-C1-4烷基,C1- 13个杂芳基和C1-13杂芳基-C1-4烷基各自任选地被1、2、3或4个独立选择的R2a基团取代;每个R1a独立地选自卤素,氰基,硝基,羟基,C1-4烷氧基,C1-4卤代烷氧基,C1-4烷硫基,C1-4烷基亚磺酰基,C1-4烷基磺酰基,氨基,C1-烷基4-氨基,二-C 1-4烷基氨基,C 1-4烷基羰基,羧基,C 1-4烷氧基羰基,C 1-4烷基羰基氨基,C 1-4烷基羰基氨基,C 1-4烷氧基羰基氨基,C 1-4烷氧基羰基-( C 1-4烷基)氨基,氨基甲酰基,C 1-4烷基氨基甲酰基和二C 1-4烷基氨基甲酰基;每个R 2a独立地选自卤素,氰基,硝基,羟基,C 1-4烷基,C 1-4卤代烷基,C 2-4烯基,C 2-4炔基,C 1-4烷氧基,C 1-4卤代烷氧基,C 1-4烷基,C 1 1-4个烷基亚磺酰基,C 1-4烷基磺酰基,氨基,C 1-4烷基,二C 1-4烷基,C 1-4烷基羰基,羧基,C 1-4烷氧羰基,烷基C1-4-羰基氨基,二-C 1-4烷基羰基氨基,C 1-4烷氧基羰基氨基,C 1-4烷氧基羰基-(C 1-4烷基)氨基,氨基甲酰基,C 1-4烷基氨基甲酰基和二-C 1烷基-4-氨基甲酰基; Ra,Rb,Rc,Rd,Re和Rf各自独立地选自H,C1-6烷基,C1-6卤代烷基,C2-6烯基,C2-6炔基,C3-7环烷基,C3-7环烷基-4, C2-7杂环烷基,C2-7杂环烷基-C1-4烷基,苯基,苯基-C1-4烷基,杂芳基C1-7和杂芳基C1-7-烷基C1-4烷基;其中所述的C 1-6烷基,C 1-6卤代烷基,C 2-6烯基和C 2-6炔基各自任选地被1、2、3或4个独立选择的Rx基团取代;其中,所述C 3-7环烷基,C 3-7环烷基-C 1-4烷基,C 2-7杂环烷基,C 2-7杂环烷基-C 1-4烷基,苯基,苯基-C 1-4烷基,C 1-7个杂芳基和杂芳基C1-7-C1-4烷基各自任选地被1、2、3或4个独立选择的Ry基团取代;或任何Rc和Rd以及它们所连接的其余部分可以形成3、4、5、6或7元杂环烷基环,其中所述杂环烷基环任选地被1、2、3或4个独立选择的取代羟基,C 1-4烷基,C 1-4卤代烷基,C 1-4烷氧基,C 1-4卤代烷氧基,氨基,C 1-4烷基和二C 1-4烷基的基团;或任何Re和Rf与它们所连接的氮原子一起可以形成3、4、5、6或7元杂环烷基环或杂芳基环,其中所述杂环烷基或杂芳基环任选地被1、2取代,3或4个独立地选自羟基,C 1-4烷基,C 1-4卤代烷基,C 1-4烷氧基,C 1-4卤代烷氧基,氨基,C 1-4烷基和二C 1-4烷基的基团我;每个Rx独立地选自羟基,C 1-4烷氧基,C 1-4卤代烷氧基,氨基,C 1-4烷基和二C 1-4烷基;并且每个Ry独立地选自羟基,卤素,氰基,硝基,C 1-4烷基,C 1-4卤代烷基,C 1-4烷氧基,C 1-4卤代烷氧基,氨基,C 1-4烷基和二C 1 -4烷基-不是我;前提是不超过任选取代的残基中每个原子的化合价。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号